May 20th

4:30 pm

Badge Pick Up

5:00 pm - 6:00 pm WELCOME DAY SPECIAL CONTENT: PANEL

Welcome Day Panel: Planning for Pharmaceutical Manufacturing of the Future: What are the Five Big Things We Need to Talk About?

Vaishali Shukla

Vice President CGT & API Global Expansion

Eli Lilly

Dorothy Barr

Senior Vice President Manufacturing & Technical Operations

Lantheus

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

Vijay Raju

VP CMC

Pioneering Medicines / Flagship Pioneering

Christine Goldschneider

Head of Alliances, Manufacturing & Supply - Specialty Care

Sanofi

Session Details Arrow Icon
  • What are the key challenges affecting production speed and operational efficiency today?
  • How is the landscape of talent and workforce development evolving within the industry, and what factors are driving these changes?
  • Which cutting-edge technologies are making the greatest impact on modern pharmaceutical manufacturing?
  • What recent regulatory advancements have been made, and what opportunities exist to further streamline the approval process?
  • How can we enhance access to innovative medicines across global markets?
6:00 pm

Drinks Reception

May 21st

Stream 1 Chair

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

Stream 2 Co-Chair
Stream 3 Co-Chair
7:30 am - 8:15 am

registration & breakfast

8:15 am - 8:20 am

Opening Remarks and Important Announcements

8:20 am - 8:30 am

Chair’s Welcome Address

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

8:30 am - 9:05 am KEYNOTE

Driving Innovation and Operational Excellence: AstraZeneca’s Approach to Digital Transformation

Pam Cheng

Executive Vice President, Global Operations & Information Technology

AstraZeneca

Session Details Arrow Icon
  • How AstraZeneca navigates supply chain complexities and ensures operational continuity across global markets
  • The role of cutting-edge technology and IT innovations in optimizing manufacturing, improving efficiency, and ensuring quality at scale
  • Utilizing advanced data analytics to enhance predictive capabilities and streamline operational processes
  • AstraZeneca’s commitment to reducing its environmental impact through sustainable practices and energy-efficient operations
  • Enhancing employee performance and engagement by integrating technology into everyday workflows
  • How AstraZeneca stays ahead of regulatory changes while maintaining the highest quality and safety standards across its global operations
9:05 am - 9:40 am KEYNOTE

Transformation in Quality to Meet the Needs of Our Customers

Melissa Seymour

Executive Vice President, Global Quality

Eli Lilly

Session Details Arrow Icon

• Quality as a business driver by “Flipping the Ratio”
• Transforming business growth through Proactive Quality
• Preparing our organization for the future of Quality Assurance

9:45 am - 10:20 am Workshops
Stream One

Technical Operations Strategies for Transformative Medicines

Executive to be Announced

Project Farma

Session Details Arrow Icon
  • Discuss the shifting landscape of current trends and manufacturing strategies for next-generation medicines and their impact on technical operations
  • Best in class practices for facility planning, build, operational readiness and startup
  • New innovative technologies on the horizon
Stream Two

Maximizing Return on Automation – Benchmarking Digitization ROI

Katherine Farley

Senior Director of Product

MasterControl, Inc.

Session Details Arrow Icon
  • The Value of Digitization in Manufacturing – Automating manual tasks in manufacturing significantly reduces errors, improves efficiency, and accelerates production processes. Digital execution eliminates GDP (Good Documentation Practice) errors, reduces review and release time, and allows operators to focus on value-added tasks
  • Compounding Impact of Automation – The benefits of automation are cumulative, similar to compound interest. Transitioning from paper-based processes to digital systems can eliminate or automate up to 81% of manual data entries, leading to faster decision-making, fewer errors, and continuous process improvement
Stream Three

From “Impossible” to Commercialization

Executive to be Announced

Boehringer Ingelheim

Session Details Arrow Icon
  • Boehringer Ingelheim BioXcellence™ demonstrates how effective collaboration in contract manufacturing can expedite the delivery of innovative medicines
  • Leveraging expertise in microbial development and manufacturing
  • Toolbox approach for a groundbreaking cancer vaccine platform
  • Showcasing two perspectives from CMO and partner
  • The session will highlight the power of collaboration and innovation in the pharmaceutical industryex
10:25 am - 12:05 pm Pre-Arranged One-To-One Meetings Arrow Icon

These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.

  • 10:30 am – 10:50 am: Meeting Slot 1/Networking
  • 10:55 am – 11:15 am: Meeting Slot 2/Networking
  • 11:20 am – 11:40 am: Meeting Slot 3/Networking
  • 11:45 am – 12:05 pm: Meeting Slot 4/Networking
12:10 pm - 12:45 pm Case Studies
Stream One - Strategic Manufacturing

Accelerating Innovation and Manufacturing Excellence: Leveraging Over 30 Years of Biotech Leadership and Cell Therapy Success

Joanne Beck

Chief Technical Officer

Abata Therapeutics

Session Details Arrow Icon
  • Developing a robust manufacturing process to support clinical studies and pipeline expansion
  • How continuous improvement methodologies are applied in biotech and large pharmaceutical companies to maintain product quality, increase efficiency, and reduce costs over the product lifecycle
  • Driving operational efficiency and innovation in clinical and commercial manufacturing
  • The importance of building robust, scalable manufacturing processes in biotech, especially in partnerships like Abata’s collaboration with ElevateBio, which has transformed clinical readiness
Stream Two - Quality

Proactive Quality Management for the Future

Steve Johnson

Vice President Quality Assurance

Ultragenyx

Session Details Arrow Icon
  • Integrating human and organizational performance principles into the design of quality throughout the entire supply chain and ensuring effective implementation
  • Embracing risk-based strategies to pinpoint and address potential challenges while prioritizing essential processes and adhering to regulatory standards
  • Cultivating a culture of ongoing improvement by utilizing digital tools to streamline processes and elevate overall quality management
  • Adopting a proactive stance on regulatory compliance and operational efficiency through effective problem-solving and regular self-assessments
Stream Three - Supply Chain & Innovation

Fireside Chat: Supply Chain Revolution – Prioritizing Patients in Pharmaceutical Logistics

Judy Yeh

Vice President, Global Clinical Supply Chain

Gilead Sciences

Session Details Arrow Icon
  • Overview of the importance of prioritizing patient needs in pharmaceutical logistics and its impact on overall healthcare outcomes
  • Identification of key challenges in pharmaceutical logistics, such as delays, temperature control, and compliance with regulations
  • Exploration of advanced technologies enhancing supply chain efficiency, including IoT, blockchain, and real-time tracking systems
  • Discussion on navigating regulatory requirements and ensuring compliance while prioritizing patient needs
  • Strategies for fostering collaboration between manufacturers, distributors, and healthcare providers to create a more responsive and patient-focused supply chain
12:45 pm - 1:45 pm

General Lunch Seating

12:45 pm - 1:45 pm THEMED LUNCH DISCUSSIONS

Explore this year’s themed lunch discussions led by industry leaders, where executives engage in focused conversations over a meal, discussing topics they’re passionate about alongside their peers.

Product Stewardship Best Practices that Drive Performance and Improve Patient Outcomes

Vinod Bulusu

Exec. Director

AstraZeneca

Taking an End-to-End View of Process Optimization for New Modalities

Cliff Carroll

Executive Director, New Modalities and Platform Technology, Global Technical Operations

AstraZeneca

Scaling Digital Transformation: Driving Value to a Global Network

Rohan Mehta

GPS Digital Transformation Lead

Bristol Myers Squibb

Best Practices in Building Resilient Supplier Partnerships

Sunny Patel

Director, Global Supplier Quality Management

Gilead

Small Molecule Process Optimization: What Can We Learn from Other Industries' Cultures of Continuous Improvement?

Cedric Dubois

AVP Small Molecule Manufacturing

Merck

Seamless Execution: Harnessing the Synergy Between Project Management and Quality

Celia Baula

Executive Director, R&D Operations and Quality

Neuraly

Industry Trends, Challenges, and Opportunities in Process and Technology Platforms for the Commercialization of Gene Therapy Products

Executive to be Announced

PA Consulting Group Inc.

Supply Chain Revolution: Prioritizing Patients in Pharmaceutical Logistics

Executive to be Announced

Redaptive

From Smart Factory to Smart Network: Reaching Best in Class Performance via Digital Capabilities and AI at Scale

Inna Ben-Anat

AVP, Global Head Connected Smart Factories, Manufacturing & Supply

Sanofi

Defining Supply Assurance: How Far Should Companies Investigate and Secure Their Supply Chains?

Praveen Prasanna

Sr. Director External Manufacturing

Verve Therapeutics

1:45 pm - 2:20 pm KEYNOTE

Manufacturing Transformation: Bringing Scientific Innovation to Patients

Session Details Arrow Icon
  • Assessing global biopharmaceutical trends and disruptions to navigate industry changes and capitalize on new opportunities
  • Developing strategic initiatives to drive continuous improvement and achieve operational excellence
  • Identifying key transformation drivers and evaluating their impact on modernization efforts
  • Building agile, cross-functional teams to implement transformative strategies
  • Managing change effectively while addressing risks and utilizing digital technologies and data analytics to optimize efficiency and maintain a competitive edge
2:25 pm - 3:00 pm Workshops
Stream One

Supply Chain Digital Transformation with Business Impacts for Pharmaceutical Manufacturers

Executive to be Announced

Honeywell Life Sciences

Session Details Arrow Icon
  • Proving that the most valuable data in supply chain/manufacturing is from production itself
  • Choosing the right goals and outcomes to make a difference
  • Connecting disparate IT systems together into a unified whole
  • Building a scalable approach for the enterprise, step-by-step: Start small to go big
  • Understanding why data lakes and bespoke projects do not scale
  • Illustrating successful projects with concrete examples
Stream Two

What Traits Should Biopharma Companies Look for When Partnering with Drug Substance CDMOs?

Executive to be Announced

Axplora

Session Details Arrow Icon
  • Best traits to look for when partnering with a CDMO, besides just capabilities and capacity
  • Best practices for discerning which CDMO’s are best for biopharma companies to partner with
  • Key steps for helping biopharma companies navigate complex sales processes with CDMOs
Stream Three

Global Talent Trends in Pharma and Biotech Technical Operations: A Perfect Storm

Session Details Arrow Icon
  • The great reckoning – single-asset company valuation recalibrations reverse top talent trend and lead to unprecedented layoffs in the industry
  • The generational gap continues to progress – leading only becomes more challenging
  • Leaders in the healthcare industry indicate the greatest drop in leadership confidence across industries
3:05 pm - 4:15 pm Pre-Arranged One-To-One Meetings Arrow Icon

These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.

  • 3:05pm – 3:25pm: Meeting Slot 5/Networking
  • 3:30 pm – 3:50 pm: Meeting Slot 6/Networking
  • 3:55 pm – 4:15 pm: Meeting Slot 7/Networking
4:20 pm - 4:55 pm KEYNOTE

Regulatory Update: Advanced Manufacturing and Complex Biologic Products

Ingrid Markovic

Senior Science Advisor/CMC Lead

FDA

Session Details Arrow Icon
  • Grasping the significance of FDA-CBER’s oversight in pharma manufacturing, ensuring adherence to strict quality standards, safety measures, and ethical guidelines for global health and patient well-being
  • Discuss efforts to expedite development of products for small populations through increased use of accelerated approval
  • Review efforts toward global regulatory convergence
  • Summarize internal changes and external initiatives at FDA in support of expeditious product development
4:55 pm - 5:30 pm KEYNOTE

Innovations in Personalized Medicine Manufacturing: A Glimpse into the Future

Kathleen Munster

Chief Quality Officer

Biogen

Session Details Arrow Icon
  • The growth of biologics and precision and personalized medicine is driving the need for new types of solutions across automation, manufacturing, and quality and compliance
  • Learn how to modernize your operations and achieve manufacturing excellence using a future forward, agile, integrated, manufacturing solution that supports compliance and real-time quality management
  • Take an industry standard approach to reach new levels of maturity in your digital transformation journey
  • A look ahead at the expanding role of personalized medicine in pharma and overcoming hurdles in personalized medicine production and scalability
5:30 pm - 5:35 pm

Chair's Closing Remarks

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

5:35 pm

Drinks Reception

6:30 pm

Executive Dinner

Brought To You By

May 22nd

Stream 1 Chair

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

Stream 2 Co-Chair
Stream 2 Co-Chair
7:30 am - 8:20 am

registration & breakfast

7:45 am - 8:20 am breakfast workshops
Stream Two

Pioneering Manufacturing Automation Innovation with AI

Session Details Arrow Icon
  • Leveraging lessons learned from the semiconductor industry for tech-first companies
  • The journey of defining the high value problems and opportunities for personalized medicine
  • Optimizing productivity and quality for manufacturing resilience and sustainability
  • Speed to insights for “Right First Time”
  • Innovation enabling improvements in key achievement drivers
8:25 am - 8:35 am

Chair’s Opening Remarks

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

8:35 am - 9:10 am KEYNOTE

The Things We Can Achieve and Our Shared Journey Along the Way

Arleen Paulino

Senior Vice President Global Manufacturing

Amgen

Session Details Arrow Icon
  • The current landscape on digital innovation, technology, people and our ways of working and thinking
  • Understanding current capabilities and where we need to be collectively headed as a community of pharmaceutical manufacturers
  •  Strategies that compel and empower us to move beyond past constraints and set new, ambitious goals for the future
  • Thinking beyond the data to find purpose and meaningful connections for people
9:10 am - 9:45 am KEYNOTE

Pushing Boundaries: The Future of Pharmaceutical Manufacturing and Innovation at Moderna

Jerh Collins

Chief Technical Operations & Quality Officer

Moderna

Session Details Arrow Icon
  • Expanding manufacturing capabilities, including new sites and innovative technologies, to support an exciting pipeline of products, especially in cancer vaccines
  • How nurturing bold and curious talent fosters a mindset where taking risks is encouraged and failure is seen as a learning opportunity
  • The integration of human capital, business processes, and emerging technologies to enhance operational efficiency
  • Exploring how to work more effectively with regulatory bodies to ensure innovation isn’t stifled, while also holding them accountable
  • The role of robotics and manufacturing advancements in Europe and how these innovations shape Moderna’s global strategy
9:50 am - 10:25 am Case Studies
Stream One - Strategic Manufacturing

Advancing Gene Therapy Manufacturing: Technical Excellence and Innovation at Sarepta Therapeutics

Bilal Arif

Executive Vice President, Chief Technical Operations Officer

Sarepta Therapeutics

Session Details Arrow Icon
  • Pioneering Gene Therapy Manufacturing: Sarepta’s approach to scaling production and overcoming technical challenges in gene therapy
  • Innovative Technologies in Rare Disease Treatment: How cutting-edge tools and platforms are driving the development of treatments for rare diseases
  • Optimizing Supply Chain for Precision Medicine: Strategies for ensuring a reliable and efficient supply chain for complex, high-value therapies
  • Regulatory Compliance and Quality Assurance: Maintaining compliance and quality in a rapidly evolving regulatory landscape for gene therapies
  • Expanding Manufacturing Capabilities: Sarepta’s initiatives to grow manufacturing capacity while maintaining agility and innovation
  • Workforce Development in Advanced Therapies: Empowering technical teams to support complex manufacturing processes through specialized training and talent retention Bottom of Form
Stream Two - Quality

AI as an Enabler for a Sustainable Quality Transformation

Magaly Aham

Senior Vice President, Head Global Quality Compliance & Systems

Takeda

Session Details Arrow Icon

Global Quality Takeda is reimagining their quality commitments across the value chain. By harnessing data, digital, and emerging technologies like AI, they aim to accelerate product delivery, foster a culture of learning and innovation, and ensure environmental sustainability. They are simplifying, standardizing, and digitalizing quality processes with increased automation and AI, demonstrated through case studies such as one-day batch release, investigation reports, and APQRs. These examples highlight how AI can enable sustainable quality transformation.

Stream Three - Supply Chain & Innovation

Shaping the Future: Leading a Culture of Collaboration and Growth

Chris Stevens

Chief Patient Supply Officer

Spark Therapeutics

Session Details Arrow Icon
  • Identifying key drivers of change in the pharmaceutical industry, with a focus on workforce engagement and development
  • Strategies for building an organizational culture that prioritizes talent retention, continuous learning, and employee development
  • Analyzing whether industry changes will lead to dramatic shifts in workforce dynamics or more incremental adaptations
  • Proactive approaches to equipping teams for future uncertainties and maintaining operational resilience in a fast-changing environment
  • How the interaction between advanced technologies and human talent will redefine processes and productivity in the next decade
  • Ensuring long-term sustainability by focusing on employee well-being, skill development, and leadership empowerment
10:25 am - 11:15 am Pre-Arranged One-To-One Meetings Arrow Icon

These mutually agreed-upon conversations are arranged and facilitated by Executive Platforms staff to ensure attendees have valuable discussions about their top-of-mind questions, challenges, and opportunities.

  • 10:30 am – 10:50am: Meeting Slot 8/Networking
  • 10:55am – 11:15am: Meeting Slot 9/Networking
10:45 am - 11:15 am FOCUS GROUP

Executive focus groups are informal moderated discussions among peers, held during networking breaks outside the summit agenda. No sign-up is required; delegates and speakers can join any group of interest.

TOPIC one

Are We There Yet? – A Maturity Model for Enabling Process Monitoring and Learning in Biologics Manufacturing

Jack Prior

Head of Process Monitoring & Data Science/AI Strategy

Sanofi

11:20 am - 11:55 am Workshops
Stream One

Why Your Digital Strategy May Be Incomplete: How Legacy Models Prevent End-To-End Digital Manufacturing

Session Details Arrow Icon
  • Why pharma organizations must diversify their digitization strategy, looking beyond legacy models that prevent complete, end-to-end digital manufacturing
  • How a light, configurable MES can remove paper from production entirely and enable any-sized pharma company to fully utilize their MES across all lines and sites
  • How a modern MES can digitally connect different data sources to close offline data gaps, improve data integrity and visibility, and unlock critical business intelligence
Stream Two

The CDMO of the Future

Executive to be Announced

INCOG BioPharma Services, Inc.

Session Details Arrow Icon
  • Learn how a CDMO can be a Customer-Driven Manufacturing Organization
  • How CDMOs can use digital infrastructure to make the experience from technology transfer all the way through lifecycle management more customer-focused
  • How CDMOs can partner to integrate the supply chain to simplify processes and increase reliability
  • How strategic investments by customers with CDMOs can create value for both customer and CDMO
Stream Three

The Value of a Unified Life Sciences Solution in Pharma 4.0

Session Details Arrow Icon
  • Manage the production process and quality in real time from order to batch release in one browser-based user interface visualizing real-time and historical data
  • Streamline collaboration between manufacturing and quality people and processes to maximize throughput and accelerate batch release
  • Digitize all direct batch execution (EBR) and execution related activities (Logbooks and Digital Procedures) to eliminate paper or unstructured electronic records where data is trapped
  • Take advantage of configurable functionality
  • Analyze and report on operational data in one place for a single source of the truth
  • Achieve measurable results in cost reduction, risk mitigation, and revenue opportunities
12:00 pm - 12:35 pm Case Studies
Stream One - Strategic Manufacturing

Transforming Global Operations: Accelerating Production and Innovation at Bristol Myers Squibb

Catalina Vargas

Senior Vice President, Global Supply Chain

Bristol Myers Squibb

Session Details Arrow Icon
  • Overview of leading one of the world’s largest manufacturing operations through rapid transformation while integrating cutting edge technology
  • How GPS delivers value to the enterprise through the Product Development and R&D interface
  • The integration of Cell Therapy into GPS and how the company is working to improve predictability long-term
  • Establishing a competitive advantage for BMS from within GPS – an operational model built to last
  • Examples of GPS’s evolution to support the New Product Pipeline
Stream Two - Quality

Building a Leading Quality Management Framework

Allyson Nicholson

Vice President Global Supply Chain

BioMarin

Session Details Arrow Icon
  • Recognizing the pivotal role of quality assurance and quality control in driving key business objectives, ensuring they are strategically aligned
  • Upholding adherence to cGMPs, established policies, procedures, and industry standards to maintain regulatory compliance
  • Investing in personnel capabilities and knowledge to strengthen the effectiveness of the quality management system
  • Ensuring the efficiency and efficacy of global quality management systems across varied operational landscapes
  • Deploying advanced tools and techniques to enhance quality assurance and control practices
Stream Three - Supply Chain & Innovation

How to Enable the Digital Pharmaceutical Supply Chain of the Future Now

Paul Testa

Executive Vice President Supply Chain & Operations

Kyowa Kirin

Session Details Arrow Icon
  • Exploring how advanced data analytics and real-time monitoring can improve supply chain visibility, forecasting, and decision-making
  • Utilizing digital twin technology to create virtual models of supply chains for better simulation, optimization, and real-time problem-solving
  • Adopting digital tools to streamline compliance with regulatory requirements, ensuring product quality, safety, and adherence to evolving industry standards
  • The role of AI and machine learning in predictive maintenance, inventory management, and risk mitigation across the pharmaceutical supply chain
12:35 pm - 1:35 pm

General Lunch Seating

12:35 pm - 1:35 pm THEMED LUNCH DISCUSSIONS

Explore this year’s themed lunch discussions led by industry leaders, where executives engage in focused conversations over a meal, discussing topics they’re passionate about alongside their peers.

Sharing What Works to Optimize Costs and Productivity in Manufacturing Operations

Regis Gautier

Executive Director, Technical Operations

AstraZeneca

Realtime Manufacturing While Stabilizing the Workforce

Culture Transformation: from Compliance to Performance

Pharma 4.0: Unlocking Rapid Tech Transfer

1:35 pm - 2:10 pm KEYNOTE

Bold and Unafraid: Lessons in Leadership and the Value of Manufacturing in Building the Next Great Biotech

Timothy Maines

Chief Technical Operations & Quality Officer

Alnylam Pharmaceuticals

Session Details Arrow Icon

When all others said ‘impossible’, Alnylam turned the promise of RNAi into a proven new class of medicines and is at an inflection point to launch a blockbuster medicine. Alnylam has ambitions to address some of the world’s most prevalent diseases. Success is dependent upon fueling the potential of a deep pipeline of clinical and commercial-stage assets. The problem is, How? The answer goes beyond R&D and Commercial capabilities. As Chief of Technical Operational and Quality, Tim Maines has the experience and mindset to scale for the opportunities ahead for siRNA-based medicines and beyond. This session will discuss how to elevate manufacturing innovation as instrumental for helping the most patients by enabling companies to be big and small at the same time.

  • Case study: Delivering a new class of medicines and the role of manufacturing, supply chain and quality
  • From underappreciated to instrumental – importance of executive leadership for technical, operations and quality capabilities
  • Truths in leadership: authentic, nimble, bold, and unafraid
2:15 pm - 2:50 pm PANEL

Panel: Reflecting on the Past and Shaping the Future: Enhancing Our Influence on Medicine

Session Details Arrow Icon
  • Examining the changes within the CMC ecosystem and assessing whether we are once again overextending our capacity.
  • Addressing the risks of fragmentation: How can we improve communication, collaboration, and the consolidation of our best ideas to ensure collective success?
  • Discussing the motivations for launching new companies today and envisioning the future growth and evolution of our business ecosystem.
  • Evaluating which production platforms will be most effective for emerging modalities.
  • Considering the next steps for established platforms like mAbs, ADCs, and mRNA: How can we efficiently address significant markets, such as treatments for Alzheimer’s
2:50 pm - 3:00 pm

Chair's Closing Remarks

Charles L. Cooney

Robert T. Haslam Professor of Chemical Engineering, Emeritus, and Faculty Director, Emeritus Deshpande Center for Technological Innovation

MIT

Sign Up For Our Newsletter

"*" indicates required fields

Are you a Delegate or Solution Provider/Vendor?*

By completing and submitting this form, you agree to receive marketing emails from Executive Platforms Inc. You can opt-out at any time by utilizing the unsubscribe link provided at the bottom of each email. All data collected will be handled in accordance with our Privacy Policy and Terms of Use.

Download The Agenda PDF

"*" indicates required fields

Are you a Delegate or Solution Provider/Vendor?*

By completing and submitting this form, you agree to receive marketing emails from Executive Platforms Inc. You can opt-out at any time by utilizing the unsubscribe link provided at the bottom of each email. All data collected will be handled in accordance with our Privacy Policy and Terms of Use.